Iron status in HIV-1 infection: Implications in disease pathology

BMC Clinical Pathology

Volumn 12, Issue , 2012, Pages

  Banjoko, S Olatunbosun ^a   Oseni, Falilat A ^a   Togun, Rachel A ^a   Onayemi, Olaniyi ^a   Emma Okon, Beatrice O ^a   Fakunle, Julius B ^a  

^a OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

Author keywords

Antioxidant; Free radicals; HIV 1 infection; Iron metabolism; Pathogenesis; Prognosis

Indexed keywords

ASCORBIC ACID; IRON; SELENIUM; TRANSFERRIN; ZINC;

ACUTE PHASE RESPONSE; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON METABOLISM; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS;

EID: 84870990899     PISSN: None     EISSN: 14726890     Source Type: Journal    
DOI: 10.1186/1472-6890-12-26     Document Type: Article

References (42)

1. Metabolic abnormalities and body fat redistribution in HIV-1 infected patients: lipodystrophy syndrome. Martinez E, Gattell JM, Curr Opinium Infect Dis 1999 12 1 13 20 10.1097/00001432-199902000-00003
2. Immune modulators of HIV infection: the role of reactive oxygen species. Salman S, Berrula L, J Clin Cell Immunol 2012 3 121 10.4172/2155.9899.1000121
3. Pathophysiological implications of altered redox balance in HIV/AIDS infection: diagnosis and counteract intervention in Oxidative stress diagnosis, prevention and therapy. Gil del Valle L, ACS Symposium Series 2011 1083 37 70
4. Oxidative stress in HIV-1 infected injection user. Tang AM, Simt E, J Acq Immune Defic Synd 2000 25 512 518
5. Host pathogen interaction: the role of iron. Doherty CP, J Nut 2007 137 5 1341 1344 (Pubitemid 46701932)
6. Iron metabolism and HIV infection, reciprocal interaction with potentially harmful consequences. Savarino A, Pescarmea GP, Boelart JR, Cell Biochem Func 1999 17 279 287 10.1002/(SICI)1099-0844(199912)17:4<279::AID- CBF833>3.0.CO;2-J
7. Award WM, Iron and heam metabolism New Jersey: Wiley-Liss, Delvin TM, Textbook of biochemistry with clinical correlations. 2006 21 824- 830
8. HIV induces DCIR expression in CD4+ T cells. Lambert AA, Imbeault M, Gilbert C, Tremblay MJ, PLoS Pathog 6 11 1001188 10.1371/journal ppt.1001188
9. CD4+ and CD8+ T cells with high intracellular glutathione levels are selectively lost as the HIV infection progresses. Roaderer M, Staal FJ, Osada H, Int Immunol 1991 3 933 937 10.1093/intimm/3.9.933 1681892
10. Free radicals, antioxidants and Nutrition. Fang YZ, Yang S, Wu G, Nutrition 2002 18 10 872 879 10.1016/S0899-9007(02)00916-4 12361782 (Pubitemid 35292261)
11. Antioxidant status and lipid peroxidation in patients infected with HIV. Favier A, Sappey C, Leclero P, Faure P, Micoud M, Chem Biol Interact 1994 91 165 180 10.1016/0009-2797(94)90037-X 8194133 (Pubitemid 24168463)
12. Oxidative stress as a mediator of apoptosis. Burtke T, Sandstrom P, Immunol Today 1994 15 7 10 10.1016/0167-5699(94)90018-3 8136014 (Pubitemid 24035087)
13. Total antioxidant capacity-a novel early biochemical marker of oxidative stress in HIV infected individuals. Suresh DR, Annan V, Pratibha K, Maruti Prassad BV, J Biomed Sci 2009 16 16 10.1186/1423-0127-16-16 19272183
14. Altered iron metabolism in HIV infections:mechanism, possible consequences and proposals for management. Boelart JR, Weinberg GA, Wemberg ED, Inf Agent Dis 1996 5 36 46 (Pubitemid 26038608)
15. Haptoglobin polymorphism, iron metabolism and mortality in HIV infection. Delanghe JR, Langlois MR, Johan R, Boelart JVA, AIDS 1998 12 19 1027 1032 9662199 (Pubitemid 28276970)
16. Oxidant stress is increased during treatment of HIV-1 infection. Hulgan T, Marrow J, Richard TD, Clin Inf Dis 2003 37 1711 1717 10.1086/379776 (Pubitemid 37549961)
17. HIV and other predictors of serum folate, serum ferritin and haemoglobin in pregnancy: a cross sectional study in Zimbabwe. Frii H, Am J of Clin Nutri. 2001 73 1066 1073
18. Viral infection and iron metabolism. Drakesmith H, Prentice A, Nat Rev Microbiol 2008 6 7 541 542 10.1038/nrmicro1930 18552864 (Pubitemid 351863367)
19. Hepcidin: a direct link between iron metabolism and immunity. Vyoral D, Petrak J, Int J Biochem Cell Biol 2005 37 9 1768 1773 10.1016/j.biocel.2005.02. 023 16009323 (Pubitemid 40961662)
20. Iron, free radicals and cancer. Reizenstein P, Medical Oncology 1991 8 4 229 233
21. Iron status and indicators of human Immunodeficiency disease severity among pregnant women in Malawi. Semba RD, Taha ET, Kumwanda N, CID 2001 32 1496 1499 10.1086/320167 (Pubitemid 32424287)
22. Acute phase proteins and trace elements in asymptomatic human immunodeficiency virus infections in Nigerians. Arinola OG, Adedapo KS, Kehinde AO, Afr J Med Sc 2004 33 317 322
23. Essential trace elements and antioxidant status in relation to severity of HIV in Nigerian patients. Olaniyi JA, Arinola OG, Med Princ Pract 2001 16 420 425
24. Estimation of ascorbic acid in Clinical Chemistry: Principles and Techniques Maryland: Harper and Row, Henry R, Canon DC, Menkelman JW, 2 1966 1131
25. Association between immune activation, changes in iron metabolism and anaemia in patients with HIV infections. Fuchs D, Zangerle R, Artena-Dworzak E, Weiss G, Fritsch P, Tilz GP, Eur J Haematol 1993 50 2 90 94 8440363 (Pubitemid 23061273)
26. Oxygen derived specie: their relation to human disease and environmental stress. Halliwell B, Carrol CE, Environ Health Persp 1994 102 Supp 10 5 12
27. New perspectives on iron: an introduction. Bolt DH, Am J of Med Sc 1999 318 4 207 10.1097/00000441-199910000-00001
28. Iron status and the outcome of HIV infection: an overview. Gordeuk VR, Delanghe JR, Langlois MR, Boelaert JR, J Clin Virology. 2001 20 111 1158 10.1016/S1386-6532(00)00134-7 (Pubitemid 32106864)
29. Anti HIV effect of iron chelators: different mechanism involved. Van Asbeck BS, Geogious NA, Vander Bruggen T, Oudshoorn M, J of Clin Virology 2001 20 141 147 10.1016/S1386-6532(00)00122-0 (Pubitemid 32106870)
30. Plasma biochemical parameters as surrogate prognostic markers in HIV-1 Infected patients. Ajose OA, Banjoko SO, Olasode OA, Oyegunle VA, Fakunle JB, Res J Med Sc 2008 2 4 163 165 (Pubitemid 351780953)
31. Zinc and immune function: the biological basis of altered resistance to infection. Shankar AH, Prassad AS, Am J Clin Nutr 1998 68 2 447s 463s 9701160 (Pubitemid 28355620)
32. Selenium and aspirin in people living with HIV and AIDS in Nigeria. Durosinmi MA, Howard A, Akinola WO, Onayemi O, The Nig Postgrad Med J 2008 15 4 215 217
33. Micronutrient and HIV-1 disease progression among adults and children. Fawzi W, Clin Infec Dis 2003 37 112 116
34. Effects of antioxidants on CD4 and viral load in HIV-infected women in sub-Saharan Africa-dietary supplements versus local diet. Nkengfack GN, Torimiro JN, Englert H, Int J Vitam Nut Res 2012 82 1 63 72
35. African iron overload. Kavosie I, Gangnidzo IT, Gomon ZA, Gordeuk VR, Acta Clin Belg 2005 5 2 88 93
36. Tuberculosis and iron overload in Africa: a review. Moyo MV, Gangaidzo IT, Gordeuk VR, Kiire CF, Macphail AP, Cent Afr J Med 1997 43 334 339 9631102 (Pubitemid 127511812)
37. Iron overload in African Americans. Barton JC, Edwards CQ, Bertoli LF, Shnyer TW, Hudson SL, Am J Med 1995 99 616 623 10.1016/S0002-9343(99)80248-4 7503084 (Pubitemid 26006442)
38. Hereditary iron overload in African Americans. Baer D, Am J Med 1996 101 115 118
39. Primary iron overload in African Americans. Wurapa RK, Gordeuk VR, Brittenham GM, Khiyami A, Schechter GP, Edwards CQ, Am J Med 1996 101 9 18 10.1016/S0002-9343(96)00053-8 8686721 (Pubitemid 26285935)
40. The effect of iron overload on in vitro HIV-1infection. Traore HN, Meyer D, J Clin Virol 2004 31 Suppl 1 92 S98 15567100
41. Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. Kell DB, BMC Medical Genomics 2009 2 2 10.1186/1755-8794-2 19133145
42. Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples. Kell DB, Arch Toxicol 2010 84 825 889 10.1007/s00204-010-0577-x 20967426